Lincoln National Corp’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-36,999
| Closed | -$2.51M | – | 100 |
|
|
2024
Q1 | $2.51M | Buy |
36,999
+4,273
| +13% | +$289K | 0.04% | 281 |
|
|
2023
Q4 | $2.2M | Buy |
32,726
+899
| +3% | +$60.5K | 0.04% | 270 |
|
|
2023
Q3 | $2.16M | Buy |
31,827
+954
| +3% | +$64.6K | 0.04% | 233 |
|
|
2023
Q2 | $2.21M | Buy |
30,873
+1,218
| +4% | +$87.2K | 0.04% | 232 |
|
|
2023
Q1 | $2.06M | Buy |
29,655
+2,845
| +11% | +$197K | 0.04% | 226 |
|
|
2022
Q4 | $1.82M | Sell |
26,810
-4,211
| -14% | -$286K | 0.04% | 238 |
|
|
2022
Q3 | $1.7M | Buy |
31,021
+601
| +2% | +$33K | 0.04% | 234 |
|
|
2022
Q2 | $2.01M | Sell |
30,420
-555
| -2% | -$36.7K | 0.05% | 209 |
|
|
2022
Q1 | $2.06M | Buy |
30,975
+853
| +3% | +$56.6K | 0.04% | 224 |
|
|
2021
Q4 | $1.76M | Sell |
30,122
-483
| -2% | -$28.1K | 0.04% | 240 |
|
|
2021
Q3 | $1.84M | Buy |
30,605
+16,920
| +124% | +$1.02M | 0.04% | 216 |
|
|
2021
Q2 | $819K | Buy |
13,685
+2,079
| +18% | +$124K | 0.02% | 360 |
|
|
2021
Q1 | $577K | Buy |
11,606
+249
| +2% | +$12.4K | 0.01% | 426 |
|
|
2020
Q4 | $568K | Buy |
11,357
+634
| +6% | +$31.7K | 0.02% | 387 |
|
|
2020
Q3 | $588K | Buy |
10,723
+928
| +9% | +$50.9K | 0.02% | 350 |
|
|
2020
Q2 | $518K | Buy |
9,795
+2,328
| +31% | +$123K | 0.02% | 366 |
|
|
2020
Q1 | $333K | Buy |
7,467
+2,744
| +58% | +$122K | 0.01% | 424 |
|
|
2019
Q4 | $235K | Buy |
+4,723
| New | +$235K | 0.01% | 557 |
|
|
2019
Q3 | – | Sell |
-5,897
| Closed | -$243K | – | 578 |
|
|
2019
Q2 | $243K | Buy |
+5,897
| New | +$243K | 0.01% | 475 |
|